Invention Grant
- Patent Title: Dioxolane analogues of uridine for the treatment of cancer
-
Application No.: US16459165Application Date: 2019-07-01
-
Publication No.: US10654877B2Publication Date: 2020-05-19
- Inventor: Richard Bethell , Anders Eneroth , Bjorn Klasson , Fredrik Oberg
- Applicant: MEDIVIR AB
- Applicant Address: SE Stockholm
- Assignee: MEDIVIR AB
- Current Assignee: MEDIVIR AB
- Current Assignee Address: SE Stockholm
- Agency: Gorman IP Law, APC
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@602f77b com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@59039765
- Main IPC: A61K31/506
- IPC: A61K31/506 ; C07F9/6558 ; C07D405/04 ; A61K31/675 ; A61K45/06 ; C07F9/24

Abstract:
The invention provides compounds of the formula: R1 is OR11, or NR5R5′; R2 is H or F; R5 is H, C1-C6alkyl, OH, C(═O)R6, O(C═O)R6 or O(C═O)OR6; R5′ is H or C1-C6alkyl; R6 is C1-C6alkyl or C3-C7cycloalkyl; R13 is H, phenyl, pyridyl, benzyl, indolyl or naphthyl wherein the phenyl, pyridyl, benzyl, indolyl and naphthyl is optionally substituted with 1, 2 or 3 R22; and the other variables are as defined in the claims, which are of use in the treatment of cancer, and related aspects.
Public/Granted literature
- US20190389890A1 DIOXOLANE ANALOGUES OF URIDINE FOR THE TREATMENT OF CANCER Public/Granted day:2019-12-26
Information query
IPC分类: